nodes	percent_of_prediction	percent_of_DWPC	metapath
Gliclazide—VEGFA—miR-148a/miR-31/FIH1/HIF1α-Notch signaling in glioblastoma —HES1—meningioma	0.154	0.154	CbGpPWpGaD
Gliclazide—VEGFA—S1P1 pathway—PDGFB—meningioma	0.0591	0.0591	CbGpPWpGaD
Gliclazide—VEGFA—Angiogenesis—PDGFB—meningioma	0.049	0.049	CbGpPWpGaD
Gliclazide—VEGFA—S1P3 pathway—PDGFB—meningioma	0.0475	0.0475	CbGpPWpGaD
Gliclazide—VEGFA—Beta3 integrin cell surface interactions—PLAUR—meningioma	0.0425	0.0425	CbGpPWpGaD
Gliclazide—VEGFA—Signaling events mediated by TCPTP—PDGFB—meningioma	0.0326	0.0326	CbGpPWpGaD
Gliclazide—VEGFA—Beta3 integrin cell surface interactions—PDGFB—meningioma	0.0308	0.0308	CbGpPWpGaD
Gliclazide—VEGFA—Beta1 integrin cell surface interactions—PLAUR—meningioma	0.0302	0.0302	CbGpPWpGaD
Gliclazide—VEGFA—Beta3 integrin cell surface interactions—PLAU—meningioma	0.0298	0.0298	CbGpPWpGaD
Gliclazide—VEGFA—Differentiation Pathway—PDGFB—meningioma	0.0282	0.0282	CbGpPWpGaD
Gliclazide—VEGFA—Bladder Cancer—ERBB2—meningioma	0.0268	0.0268	CbGpPWpGaD
Gliclazide—VEGFA—SHP2 signaling—PDGFB—meningioma	0.0242	0.0242	CbGpPWpGaD
Gliclazide—VEGFA—Endochondral Ossification—PLAU—meningioma	0.0217	0.0217	CbGpPWpGaD
Gliclazide—VEGFA—Beta1 integrin cell surface interactions—PLAU—meningioma	0.0212	0.0212	CbGpPWpGaD
Gliclazide—VEGFA—Platelet degranulation—PDGFB—meningioma	0.0187	0.0187	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—CST3—meningioma	0.0185	0.0185	CbGpPWpGaD
Gliclazide—VEGFA—Response to elevated platelet cytosolic Ca2+—PDGFB—meningioma	0.0178	0.0178	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—SMO—meningioma	0.0166	0.0166	CbGpPWpGaD
Gliclazide—VEGFA—Angiogenesis—AKT1—meningioma	0.0162	0.0162	CbGpPWpGaD
Gliclazide—VEGFA—S1P3 pathway—AKT1—meningioma	0.0156	0.0156	CbGpPWpGaD
Gliclazide—VEGFA—Bladder Cancer—TP53—meningioma	0.0156	0.0156	CbGpPWpGaD
Gliclazide—VEGFA—VEGFR1 specific signals—AKT1—meningioma	0.0139	0.0139	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—HES1—meningioma	0.0128	0.0128	CbGpPWpGaD
Gliclazide—ABCC8—FOXA2 and FOXA3 transcription factor networks—AKT1—meningioma	0.0109	0.0109	CbGpPWpGaD
Gliclazide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—AKT1—meningioma	0.0106	0.0106	CbGpPWpGaD
Gliclazide—VEGFA—Focal Adhesion—PDGFB—meningioma	0.00937	0.00937	CbGpPWpGaD
Gliclazide—VEGFA—Oncostatin M Signaling Pathway—TP53—meningioma	0.00862	0.00862	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—PDGFB—meningioma	0.0083	0.0083	CbGpPWpGaD
Gliclazide—VEGFA—Integrins in angiogenesis—AKT1—meningioma	0.00746	0.00746	CbGpPWpGaD
Gliclazide—VEGFA—Endochondral Ossification—AKT1—meningioma	0.00737	0.00737	CbGpPWpGaD
Gliclazide—VEGFA—Oncostatin M Signaling Pathway—AKT1—meningioma	0.00728	0.00728	CbGpPWpGaD
Gliclazide—VEGFA—HIF-1-alpha transcription factor network—AKT1—meningioma	0.00719	0.00719	CbGpPWpGaD
Gliclazide—VEGFA—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—meningioma	0.00702	0.00702	CbGpPWpGaD
Gliclazide—ALB—Platelet degranulation—PDGFB—meningioma	0.0066	0.0066	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—PTEN—meningioma	0.00643	0.00643	CbGpPWpGaD
Gliclazide—ALB—Response to elevated platelet cytosolic Ca2+—PDGFB—meningioma	0.00629	0.00629	CbGpPWpGaD
Gliclazide—VEGFA—Focal Adhesion—ERBB2—meningioma	0.00628	0.00628	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	0.00625	0.00625	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—ALAD—meningioma	0.00618	0.00618	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—ALAD—meningioma	0.00599	0.00599	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—PLAUR—meningioma	0.00592	0.00592	CbGpPWpGaD
Gliclazide—VEGFA—Focal Adhesion—PTEN—meningioma	0.00535	0.00535	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	0.00533	0.00533	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—HES1—meningioma	0.0051	0.0051	CbGpPWpGaD
Gliclazide—VEGFA—VEGFA-VEGFR2 Pathway—AKT1—meningioma	0.00488	0.00488	CbGpPWpGaD
Gliclazide—VEGFA—Signaling by VEGF—AKT1—meningioma	0.00461	0.00461	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—TP53—meningioma	0.00439	0.00439	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—PDGFB—meningioma	0.00428	0.00428	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—PLAU—meningioma	0.00415	0.00415	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—ERBB2—meningioma	0.0041	0.0041	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—TSHB—meningioma	0.00398	0.00398	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—TSHB—meningioma	0.00386	0.00386	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—AKT1—meningioma	0.00371	0.00371	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—meningioma	0.00364	0.00364	CbGpPWpGaD
Gliclazide—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—meningioma	0.00351	0.00351	CbGpPWpGaD
Gliclazide—VEGFA—Focal Adhesion—AKT1—meningioma	0.00309	0.00309	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.00307	0.00307	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TSHB—meningioma	0.00304	0.00304	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—TP53—meningioma	0.003	0.003	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—PDGFB—meningioma	0.00293	0.00293	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—ERBB2—meningioma	0.00292	0.00292	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—TP53—meningioma	0.00281	0.00281	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—AKT1—meningioma	0.00273	0.00273	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—SMO—meningioma	0.00259	0.00259	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PGR—meningioma	0.00248	0.00248	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—PLAUR—meningioma	0.00209	0.00209	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ALAD—meningioma	0.00199	0.00199	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ALAD—meningioma	0.00179	0.00179	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—HES1—meningioma	0.0017	0.0017	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—TP53—meningioma	0.00167	0.00167	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ALAD—meningioma	0.00163	0.00163	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—PDGFB—meningioma	0.00151	0.00151	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—PLAU—meningioma	0.00147	0.00147	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PDGFB—meningioma	0.00145	0.00145	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—AKT1—meningioma	0.00144	0.00144	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—AKT1—meningioma	0.00141	0.00141	CbGpPWpGaD
Gliclazide—ALB—Metabolism—TSHB—meningioma	0.00128	0.00128	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—TSHB—meningioma	0.00115	0.00115	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PTEN—meningioma	0.00109	0.00109	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PTEN—meningioma	0.00105	0.00105	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—TSHB—meningioma	0.00105	0.00105	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—ERBB2—meningioma	0.000972	0.000972	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—AKT1—meningioma	0.000965	0.000965	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PTEN—meningioma	0.000829	0.000829	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000786	0.000786	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000705	0.000705	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000643	0.000643	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—AKT1—meningioma	0.000625	0.000625	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—AKT1—meningioma	0.000606	0.000606	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—TP53—meningioma	0.000589	0.000589	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TP53—meningioma	0.000566	0.000566	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—AKT1—meningioma	0.000497	0.000497	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—AKT1—meningioma	0.000478	0.000478	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PTEN—meningioma	0.00035	0.00035	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PTEN—meningioma	0.000314	0.000314	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PTEN—meningioma	0.000286	0.000286	CbGpPWpGaD
Gliclazide—ALB—Metabolism—AKT1—meningioma	0.000202	0.000202	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—AKT1—meningioma	0.000181	0.000181	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—AKT1—meningioma	0.000165	0.000165	CbGpPWpGaD
